Skip to content Skip to footer

Pfizer and Moderna Hike EU Vaccine Prices as Rich Countries Oppose Patent Waiver

The two companies are already expected to rake in tens of billions of dollars this year from vaccine sales.

A health worker prepares a dose of the Moderna COVID-19 vaccine at a vaccination center in San Salvador, El Salvador, on July 28, 2021.

With some of the world’s wealthiest countries continuing to oppose temporary patent waivers for Covid-19 vaccines in order to more rapidly deploy life-saving shots worldwide, pharmaceutical giants Pfizer and Moderna have raised the price for European Union orders.

In its new supply contract with the E.U., Pfizer named a price of more than $23 per dose, up nearly 25% from about $18 on earlier purchases. Moderna said in its latest agreement that its mRNA vaccine will cost one-tenth more than its previous price, charging $25.50 per dose.

The two companies plan to provide the E.U. with 2.1 billion vaccine doses until 2023, and are already expected to rake in tens of billions of dollars this year from vaccine sales.

“Capitalism never fails to not surprise,” tweeted The New Yorker writer John Cassidy in response to reporting from the Financial Times.

With patent protections kept in place by the World Trade Organization (WTO) as E.U. countries including Germany, Switzerland, and the United Kingdom oppose lifting Trade-Related Aspects of Intellectual Property Rights (TRIPS) for Covid-19-related products, vaccine doses have mainly been available in wealthy countries.

According to the New York Times‘ latest analysis, 0.3% of doses have been administered in low-income countries, leading public health experts to warn that Covid-19 will continue to mutate and dangerous, highly infectious variants like Delta will continue to emerge and spread throughout the world.

The companies are raising their prices “just in time for the Delta variant,” one observer wrote on Twitter.

Pfizer and Moderna have raised their prices as Europe faces supply chain issues with the Johnson & Johnson and AstraZeneca vaccines — the latter of which has been more widely available in low-income countries — and as new studies showed higher efficacy of the mRNA vaccines compared to the cheaper shots.

An official involved in the price negotiations told the Financial Times that Pfizer and Moderna used the “usual pharma rhetoric” in discussing the price hikes.

“Vaccines work so they increased the ‘value,'” the official said.

With the two companies continuing to sell most of its supply to high-income countries, Pfizer’s sales are now expected to reach $56 billion and Moderna’s are expected to reach $30 billion.

“E.U., care to rethink your position on a patent waiver?,” tweeted Nick Dearden, director of Global Justice Now, which has been calling for the WTO to lift patent protections for Covid-19 vaccines for months.

Intellectual property lawyer Tahir Amin wrote on social media that lifting patent protections for vaccines, as South African and Indian WTO representatives first proposed last year, would suspend the tool “that enables and supports this monopoly” controlled by Big Pharma.

“Our governments are complicit in this heist by pharma and companies across the board in other sectors,” Amin said.

Help us Prepare for Trump’s Day One

Trump is busy getting ready for Day One of his presidency – but so is Truthout.

Trump has made it no secret that he is planning a demolition-style attack on both specific communities and democracy as a whole, beginning on his first day in office. With over 25 executive orders and directives queued up for January 20, he’s promised to “launch the largest deportation program in American history,” roll back anti-discrimination protections for transgender students, and implement a “drill, drill, drill” approach to ramp up oil and gas extraction.

Organizations like Truthout are also being threatened by legislation like HR 9495, the “nonprofit killer bill” that would allow the Treasury Secretary to declare any nonprofit a “terrorist-supporting organization” and strip its tax-exempt status without due process. Progressive media like Truthout that has courageously focused on reporting on Israel’s genocide in Gaza are in the bill’s crosshairs.

As journalists, we have a responsibility to look at hard realities and communicate them to you. We hope that you, like us, can use this information to prepare for what’s to come.

And if you feel uncertain about what to do in the face of a second Trump administration, we invite you to be an indispensable part of Truthout’s preparations.

In addition to covering the widespread onslaught of draconian policy, we’re shoring up our resources for what might come next for progressive media: bad-faith lawsuits from far-right ghouls, legislation that seeks to strip us of our ability to receive tax-deductible donations, and further throttling of our reach on social media platforms owned by Trump’s sycophants.

We’re preparing right now for Trump’s Day One: building a brave coalition of movement media; reaching out to the activists, academics, and thinkers we trust to shine a light on the inner workings of authoritarianism; and planning to use journalism as a tool to equip movements to protect the people, lands, and principles most vulnerable to Trump’s destruction.

We’re asking all of our readers to start a monthly donation or make a one-time donation – as a commitment to stand with us on day one of Trump’s presidency, and every day after that, as we produce journalism that combats authoritarianism, censorship, injustice, and misinformation. You’re an essential part of our future – please join the movement by making a tax-deductible donation today.

If you have the means to make a substantial gift, please dig deep during this critical time!

With gratitude and resolve,

Maya, Negin, Saima, and Ziggy